COMIRNATY JN.1 émuls inj 30 mcg/dose ser pr 10 pce

7680699130016 Pharmacode 7853900 CH-69913 J07BN01 08.08.
COMIRNATY JN.1 émuls inj 30 mcg/dose ser pr 10 pce
COMIRNATY JN.1 émuls inj 30 mcg/dose ser pr 10 pce
COMIRNATY JN.1 émuls inj 30 mcg/dose ser pr 10 pce
1 / 3
google

Details

GTIN
7680699130016
Pharmacode
7853900
Product number
6991301
CPT
-
Packaging group
10
Unit
Fertigspritze(n)
Composition
Suspension: bretovameranum 1 Dosis à 0.3 ml 30 µg pro dosi, ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diylis)bis(2-hexyldecanoas), 2-(polyethylenglycoli 2000)-N,N-ditetradecylacetamidum, 1,2-distearoyl-sn-glycero-3-phosphocholinum, cholesterolum, saccharum, trometamolum, trometamoli hydrochloridum, aqua ad iniectabile, 1 ml corresp..

Articles (1)

Comirnaty JN.1 0.042 mg, Injektionsdispersion in einer Fertigspritze
Fertigspritze
10
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
bretovameranum
30.0 UG Substance Wirkstoff (Principe actif)
((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diylis)bis(2-hexyldecanoas)
- Substance HNIDK
2-(polyethylenglycoli 2000)-N,N-ditetradecylacetamidum
- Substance HNIDK
1,2-distearoyl-sn-glycero-3-phosphocholinum
- Substance HNIDK
cholesterolum
- Substance HNIDK
saccharum
- Substance HNIDK
trometamolum
- Substance HNIDK
trometamoli hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
69913
Drug name
Comirnaty JN.1, Injektionsdispersion in einer Fertigspritze
Galenic form
DISIJ
ATC Code
J07BN01
Authorization status
Revoked/Withdrawn
Dispensation category
B
First authorization
12/08/2024
Authorization expiration date
17/01/2026
IT number
08.08.
Domain
Human medicine
Field of application
Comirnaty JN.1 (30 Mikrogramm)/Dosis gebrauchsfertige Injektionsdispersion ist indiziert für die aktive Immunisierung zur Vorbeugung der durch das SARS-CoV-2-Virus hervorgerufenen COVID-19-Erkrankung bei Personen ab 12 Jahren.

Packaging details

Description (FR)
COMIRNATY JN.1 émuls inj 30 mcg/dose ser pr 10 pce
Description (DE)
COMIRNATY JN.1 Inj Emuls 30 mcg/Dosis Fe Sp 10 Stk
Market launch
12/08/2024
Market withdrawal
17/01/2025
Narcotic (BTM)
No

Other packaging sizes

Buy us a coffee Explore the data